See more : Onto Innovation Inc. (ONTO) Income Statement Analysis – Financial Results
Complete financial analysis of Café Serendipity Holdings, Inc. (CAFS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Café Serendipity Holdings, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Valhi, Inc. (VHI) Income Statement Analysis – Financial Results
- Beasley Broadcast Group, Inc. (BBGI) Income Statement Analysis – Financial Results
- PBsystems,Inc. (4447.T) Income Statement Analysis – Financial Results
- Thunderbird Entertainment Group Inc. (TBRD.V) Income Statement Analysis – Financial Results
- Honey Hope Honesty Enterprise Co.,Ltd (8043.TWO) Income Statement Analysis – Financial Results
Café Serendipity Holdings, Inc. (CAFS)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Café Serendipity Holdings, Inc.
Café Serendipity Holdings, Inc., a development stage company, focuses on building upscale turnkey franchises to the recreational and medical marijuana industry in the United States. It intends to market a product line of accessories, apparel, coffee and teas, bakery and other edibles, lotions, marijuana, and oils through a coast to coast franchise and dealer network to the recreational and the approximately 6,000 existing legal medical marijuana dispensaries. The company is based in Newport Beach, California.
| Metric | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|
| Revenue | 44.56K | 7.45K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 43.36K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.20K | 7.45K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 2.68% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 115.43K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.42M | 1.27M | 282.27K | 269.36K | 0.00 | 30.87K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.42M | 1.27M | 282.27K | 269.36K | 69.80K | 30.87K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.44M | 1.27M | 397.70K | 269.36K | 69.80K | 30.87K |
| Cost & Expenses | 1.48M | 1.27M | 397.70K | 269.36K | 69.80K | 30.87K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 83.54K | 43.85K | 2.02K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 19.80K | 49.67K | 45.60K | 0.00 | 0.00 | 0.00 |
| EBITDA | -1.42M | -1.21M | -352.10K | -269.36K | -69.80K | -30.87K |
| EBITDA Ratio | -4,901.31% | -3,227.86% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.44M | -1.91M | -397.70K | -269.36K | -69.80K | -30.87K |
| Operating Income Ratio | -3,220.95% | -25,608.78% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 768.48K | -129.62K | -2.02K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -666.61K | -2.88M | -399.72K | -269.36K | -69.80K | 0.00 |
| Income Before Tax Ratio | -1,496.16% | -38,679.90% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -684.94K | 1.02M | 0.00 | 0.00 | 0.00 | 30.87K |
| Net Income | -750.16K | -2.28M | -399.72K | -269.36K | -69.80K | -30.87K |
| Net Income Ratio | -1,683.67% | -30,625.27% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.86 | -2.94 | -0.52 | -1.97 | -5.58 | -0.18 |
| EPS Diluted | -0.86 | -2.94 | -0.52 | -1.97 | -5.58 | -0.18 |
| Weighted Avg Shares Out | 872.69K | 777.38K | 765.02K | 136.97K | 12.50K | 167.60K |
| Weighted Avg Shares Out (Dil) | 872.69K | 777.38K | 765.02K | 136.97K | 12.50K | 167.60K |
Source: https://incomestatements.info
Category: Stock Reports